OBJECTIVE: Our objective was to investigate how postprandial processing of intact proinsulin is influenced by different pharmacological strategies in type 2 diabetes mellitus (T2DM). MATERIALS/ METHODS: This exploratory, nonrandomized, cross-sectional study recruited T2DM patients and healthy subjects. Upon recruitment, eligible T2DM patients had been treated for ≥6 months with insulin glargine (GLA) plus metformin (MET), sulfonylureas (SU) plus MET, or dipeptidyl-peptidase-4 inhibitors (DPP-4-I) plus MET. Blood samples were drawn from study participants after an 8 h fast and at regular intervals for up to 5 h after consumption of a standardized meal. Study endpoints included postprandial intact proinsulin and insulin levels and the insulin/proinsulin ratio. RESULTS: As expected, postprandial secretion of proinsulin was greater in all T2DM treatment groups than in healthy subjects (p < .01 for all comparisons). Postprandial release of proinsulin was significantly greater in T2DM patients treated with SU plus MET than in those treated with GLA plus MET (p = .003). Treatment with DPP-4-I plus MET was associated with reduced proinsulin secretion versus SU plus MET and an increased insulin/proinsulin ratio versus the other T2DM groups. CONCLUSIONS: Treatment of T2DM with GLA plus MET or DPP-4-I plus MET was associated with a more physiological postprandial secretion pattern of the β cell compared with those treated with SU plus MET.
OBJECTIVE: Our objective was to investigate how postprandial processing of intact proinsulin is influenced by different pharmacological strategies in type 2 diabetes mellitus (T2DM). MATERIALS/ METHODS: This exploratory, nonrandomized, cross-sectional study recruited T2DM patients and healthy subjects. Upon recruitment, eligible T2DM patients had been treated for ≥6 months with insulin glargine (GLA) plus metformin (MET), sulfonylureas (SU) plus MET, or dipeptidyl-peptidase-4 inhibitors (DPP-4-I) plus MET. Blood samples were drawn from study participants after an 8 h fast and at regular intervals for up to 5 h after consumption of a standardized meal. Study endpoints included postprandial intact proinsulin and insulin levels and the insulin/proinsulin ratio. RESULTS: As expected, postprandial secretion of proinsulin was greater in all T2DM treatment groups than in healthy subjects (p < .01 for all comparisons). Postprandial release of proinsulin was significantly greater in T2DM patients treated with SU plus MET than in those treated with GLA plus MET (p = .003). Treatment with DPP-4-I plus MET was associated with reduced proinsulin secretion versus SU plus MET and an increased insulin/proinsulin ratio versus the other T2DM groups. CONCLUSIONS: Treatment of T2DM with GLA plus MET or DPP-4-I plus MET was associated with a more physiological postprandial secretion pattern of the β cell compared with those treated with SU plus MET.
Authors: Andreas Pfützner; Babette Lorra; Michel R Abdollahnia; Peter H Kann; Dominik Mathieu; Christine Pehnert; Christina Oligschleger; Marcel Kaiser; Thomas Forst Journal: Diabetes Technol Ther Date: 2006-06 Impact factor: 6.118
Authors: Marjan Alssema; Jacqueline M Dekker; Giel Nijpels; Coen D A Stehouwer; Lex M Bouter; Robert J Heine Journal: Diabetes Care Date: 2005-04 Impact factor: 19.112
Authors: M E Røder; B Dinesen; S G Hartling; P Houssa; H Vestergaard; F Sodoyez-Goffaux; C Binder Journal: Diabetes Care Date: 1999-04 Impact factor: 19.112
Authors: A Festa; R D'Agostino; L Mykkänen; R P Tracy; D J Zaccaro; C N Hales; S M Haffner Journal: Arterioscler Thromb Vasc Biol Date: 1999-03 Impact factor: 8.311
Authors: K Kirchhoff; F Machicao; A Haupt; S A Schäfer; O Tschritter; H Staiger; N Stefan; H-U Häring; A Fritsche Journal: Diabetologia Date: 2008-02-09 Impact factor: 10.122
Authors: Andreas Pfützner; Iris Hermanns; Sanja Ramljak; Filiz Demircik; Anke H Pfützner; Peter H Kann; Matthias M Weber Journal: J Diabetes Sci Technol Date: 2015-09-29
Authors: Stefan Pscherer; Thomas Freude; Thomas Forst; Andreas K Nussler; Karl F Braun; Sabrina Ehnert Journal: Diabetol Metab Syndr Date: 2013-08-31 Impact factor: 3.320